Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Male Urogenital Diseases | 0.780 | 0.900 | 10 | 2005 | 2017 | ||||||
|
0.882 | 0.040 | 5 | 177095551 | missense variant | T/A | snv |
|
Neoplasms | 0.710 | 1.000 | 3 | 2009 | 2019 | ||||||||
|
5 | 177090325 | intron variant | T/C | snv | 0.83 | 0.79 |
|
0.700 | 1.000 | 3 | 2010 | 2017 | |||||||||
|
1.000 | 0.040 | 5 | 177095415 | missense variant | C/A;G | snv |
|
Neoplasms | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.080 | 5 | 177093180 | missense variant | A/G | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||||
|
0.827 | 0.160 | 5 | 177089630 | missense variant | G/A;T | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.827 | 0.160 | 5 | 177089630 | missense variant | G/A;T | snv | 0.25 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.807 | 0.080 | 5 | 177094455 | intron variant | C/T | snv | 0.19 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.080 | 5 | 177086895 | upstream gene variant | C/A | snv | 0.25 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
0.700 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
5 | 177090325 | intron variant | T/C | snv | 0.83 | 0.79 |
|
0.700 | 1.000 | 1 | 2010 | 2010 | |||||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
0.700 | 0 | ||||||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms | 0.100 | 0.917 | 12 | 2005 | 2017 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms | 0.100 | 0.909 | 11 | 2005 | 2017 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Male Urogenital Diseases | 0.080 | 0.875 | 8 | 2005 | 2017 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.050 | 1.000 | 5 | 2004 | 2018 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.050 | 1.000 | 5 | 2004 | 2018 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms | 0.040 | 0.500 | 4 | 2010 | 2013 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2007 | 2017 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2007 | 2017 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2007 | 2017 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Pathological Conditions, Signs and Symptoms | 0.030 | 1.000 | 3 | 2004 | 2015 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2005 | 2009 | ||||||
|
0.597 | 0.560 | 5 | 177093242 | missense variant | G/A | snv | 0.33 | 0.26 |
|
0.020 | 1.000 | 2 | 2006 | 2015 |